UAS regulatory sequences drive expression of Hsap\LRRK2 carrying a G2019S amino acid substitution.
Expression of Hsap\LRRK2I2020T.Scer\UAS under the control of Scer\GAL4Mhc.PW does not result in any significant difference in amplitude of miniature excitatory junction currents (mEJCs), EJCs, or quantal content of larval neuromuscular junctions, as compared to controls.
Scer\GAL4how-24B/Hsap\LRRK2G2019S.UAS is a suppressor | partially of abnormal neurophysiology | third instar larval stage phenotype of GluRIIASP16/Df(2L)cl-h4
Hsap\LRRK2G2019S.UAS, Scer\GAL4Mhc.PW is a suppressor of abnormal neurophysiology | third instar larval stage phenotype of LrrkUAS.cIa, Scer\GAL4Mhc.PW
Scer\GAL4how-24B/Hsap\LRRK2G2019S.UAS is a suppressor | partially of embryonic/larval neuromuscular junction | third instar larval stage phenotype of GluRIIASP16/Df(2L)cl-h4
Hsap\LRRK2G2019S.UAS, Scer\GAL4Mhc.PW is a suppressor of embryonic/larval neuromuscular junction | third instar larval stage phenotype of LrrkUAS.cIa, Scer\GAL4Mhc.PW
Expression of Hsap\LRRK2G2019S.Scer\UAS under the control of Scer\GAL4how-24B partially suppresses the increased quantal content observed in GluRIIASP16/Df(2L)cl-h4 mutant larval neuromuscular junctions.
Co-expression of Hsap\LRRK2G2019S.Scer\UAS suppresses the increase in excitatory junction current amplitude and quantal content seen in larvae NMJs expressing LrrkScer\UAS.cIa under the control of Scer\GAL4Mhc.PW.